Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion type Assertion NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_head.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion description "[This antiapoptotic activity is specific for death ligand/receptor-mediated apoptosis since APRIL does not protect glioma cells from the cytotoxicity of the drugs, teniposide, vincristine, lomustine or cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_provenance.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion evidence source_evidence_literature NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_provenance.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion SIO_000772 11550092 NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_provenance.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion wasDerivedFrom befree-20150227 NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_provenance.
- NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_assertion wasGeneratedBy ECO_0000203 NP803538.RAXV05e6Q21_2_0Nn_Cjg7s6HFF6O6VFiOGU6mcHolPho130_provenance.